UQCRBP1: A Potential Drug Target and Biomarker (G442454)
UQCRBP1: A Potential Drug Target and Biomarker
Unlike most genes, the UQCRBP1 gene is not encoding a protein but is a non-coding RNA (ncRNA). ncRNA plays an important role in the regulation of gene expression and can affect protein synthesis and degradation. In recent years, with the development of high-throughput sequencing technology, researchers have learned more and more about ncRNA. Many ncRNAs have been confirmed to be closely related to the occurrence and development of various diseases. Therefore, it is of high value to study the application prospects of ncRNAs in disease treatment.
UQCRBP1, the full name is ubiquinol-cytochrome c reductase binding protein pseudogene 1, belongs to a kind of ncRNA. It plays an important role in organisms and is closely related to cellular metabolism and antioxidant-related pathways. Variations in the UQCRBP1 gene are closely related to the occurrence and development of various diseases. Therefore, it is considered a potential drug target and biomarker.
First of all, studies have shown that variations in the UQCRBP1 gene are closely related to the occurrence and development of various cancers, such as lung cancer, liver cancer, breast cancer, etc. In cancer patients, UQCRBP1 expression levels are often higher, which may be due to enhanced metabolism and reduced antioxidant capacity of cancer cells. Therefore, by reducing the expression level of UQCRBP1 gene, the growth and metastasis of cancer cells can be inhibited, thereby improving the survival rate of tumor patients.
Secondly, variations in the UQCRBP1 gene are closely related to the occurrence and development of neurodegenerative diseases. For example, neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease are closely related to variations in the UQCRBP1 gene. Research has found that variations in the UQCRBP1 gene are closely related to neuronal death and neuronal synapse loss, which provides new ideas for the treatment of neurodegenerative diseases.
In addition, variations in the UQCRBP1 gene are closely related to the occurrence and development of liver diseases. The liver is an important metabolic organ in the human body, and variations in the UQCRBP1 gene are closely related to the onset and development of liver diseases. Studies have shown that variations in the UQCRBP1 gene are closely related to the occurrence of diseases such as liver fibrosis and cirrhosis, which provides new targets for the treatment of liver diseases.
In summary, variations in the UQCRBP1 gene are closely related to the occurrence and development of various diseases. Therefore, it is a potential drug target and biomarker. By reducing the expression level of the UQCRBP1 gene, the growth and metastasis of cancer cells can be inhibited, thereby improving the survival rate of tumor patients. In addition, variations in the UQCRBP1 gene are closely related to the occurrence and development of neurodegenerative diseases, liver diseases and other diseases. Therefore, future research on the relationship between UQCRBP1 gene variation and disease will provide new ideas and methods for disease treatment.
Protein Name: Ubiquinol-cytochrome C Reductase Binding Protein Pseudogene 1
The "UQCRBP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about UQCRBP1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
UQCRC1 | UQCRC2 | UQCRC2P1 | UQCRFS1 | UQCRFS1P1 | UQCRH | UQCRHL | UQCRQ | URAD | URAHP | URB1 | URB1-AS1 | URB2 | Urea transporter | URGCP | URGCP-MRPS24 | URI1 | Uridine phosphorylase | URM1 | UROC1 | UROD | UROS | USB1 | USE1 | USF1 | USF2 | USF3 | USH1C | USH1G | USH2A | USHBP1 | USO1 | USP1 | USP1-UAF1 complex | USP10 | USP11 | USP12 | USP12-AS1 | USP12-DT | USP13 | USP14 | USP15 | USP16 | USP17L1 | USP17L10 | USP17L11 | USP17L12 | USP17L13 | USP17L14P | USP17L15 | USP17L17 | USP17L18 | USP17L2 | USP17L20 | USP17L21 | USP17L24 | USP17L25 | USP17L26 | USP17L27 | USP17L29 | USP17L3 | USP17L5 | USP17L6P | USP17L7 | USP17L8 | USP17L9P | USP18 | USP19 | USP2 | USP2-AS1 | USP20 | USP21 | USP22 | USP24 | USP25 | USP26 | USP27X | USP27X-DT | USP28 | USP29 | USP3 | USP3-AS1 | USP30 | USP30-AS1 | USP31 | USP32 | USP32P1 | USP32P2 | USP32P3 | USP33 | USP34 | USP35 | USP36 | USP37 | USP38 | USP39 | USP4 | USP40 | USP41 | USP42
